Phase I Study of Vorinostat in Combination with Decitabine in Patients with Relapsed or Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

被引：0
|
作者：
Kirschbaum, Mark [1 ]
Gojo, Ivana [2 ]
Goldberg, Stuart L. [3 ]
Kujawski, Lisa [4 ]
Atallah, Ehab [5 ]
Marks, Peter [6 ]
Garcia-Vargas, Jose [7 ]
Rizvi, Syed [7 ]
Di Gravio, Donna [7 ]
Ahern, Janet [7 ]
Issa, Jean-Pierre [8 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA
[3] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[6] Yale Univ, Sch Med, New Haven, CT USA
[7] Merck & Co Inc, Upper Gwynedd, PA USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1250 / 1250
页数：1
相关论文
共 50 条
  • [41] Phase I trial of sodium salicylate in patients with myelodysplastic syndromes and acute myelogenous leukemia
    Klimek, Virginia M.
    Dolezal, Emily K.
    Smith, Larry
    Soff, Gerald
    Nimer, Stephen D.
    LEUKEMIA RESEARCH, 2012, 36 (05) : 570 - 574
  • [42] A phase II study of sequential decitabine and rapamycin in acute myelogenous leukemia
    Liesveld, Jane L.
    Baran, Andrea
    Azadniv, Mitra
    Misch, Haley
    Nedrow, Katherine
    Becker, Michael
    Loh, Kah Poh
    O'Dwyer, Kristen M.
    Mendler, Jason H.
    LEUKEMIA RESEARCH, 2022, 112
  • [43] Patient-Reported Outcome Measures Associated with Overall Survival and Acute Care Use in Patients with Newly Diagnosed Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Acute Lymphoblastic Leukemia
    Villalona, Seiichi
    Wang, Xin
    Gabriel, Peter
    Doucette, Abigail
    McCurdy, Shannon R.
    Perl, Alexander
    Luger, Selina M.
    Frey, Noelle V.
    Bruno, Ximena Jordan
    Hexner, Elizabeth O.
    Babushok, Daria V.
    Porter, David L.
    Loren, Alison W.
    Pratz, Keith W.
    Lai, Catherine
    BLOOD, 2023, 142
  • [44] Final update of phase I-II study of the farnesyltransferase inhibitor tipifarnib in combination with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
    Delmonte, John, Jr.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Estrov, Zeev
    Ravandi, Farhad
    Verstovsek, Srdan
    O'Brien, Susan
    Koller, Charles A.
    Faderl, Stefan
    Thomas, Deborah A.
    Wright, John J.
    Cortes, Jorge
    BLOOD, 2007, 110 (11) : 136A - 136A
  • [45] A Phase I/II Study of Combination of Azacitidine, Venetoclax and Pevonedistat in Patients with Newly-Diagnosed Secondary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Hypomethylating Agent (HMA) Failure
    Ong, Faustine
    Garcia-Manero, Guillermo
    Montalban-Bravo, Guillermo
    Alvarado, Yesid
    Ohanian, Maro
    Konopleva, Marina
    Jabbour, Elias
    Jain, Nitin
    Borthakur, Gautam
    DiNardo, Courtney D.
    Daver, Naval
    Issa, Ghayas C.
    Sasaki, Koji
    Chien, Kelly S.
    Takahashi, Koichi
    Andreeff, Michael
    Muftuoglu, Muharrem
    Delumpa, Ricardo
    Mayor, Ejiroghene
    Loiselle, Christopher
    Waller, Lourdes
    Banks, Glenda
    Kantarjian, Hagop
    Cortes, Jorge E.
    Short, Nicholas
    BLOOD, 2022, 140 : 6206 - 6208
  • [46] Phase 2 Study of Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome- Outcome in Previously Untreated Patients.
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Estrov, Zeev
    Konopleva, Marina
    Burger, Jan A.
    Thomas, Deborah A.
    Kadia, Tapan
    Williams, Betsy
    George, Sully
    Kantarjian, Hagop
    BLOOD, 2009, 114 (22) : 435 - 436
  • [47] Update of a phase I study of sorafenib in patients with refractory/relapsed acute myeloid leukemia or high-risk myelodysplastic syndrome
    Delmonte, John, Jr.
    Kantarjian, Hagop M.
    Andreef, Michael
    Faderl, Stefan
    Wright, John J.
    Zhang, Weiguo
    Konopleva, Marina
    Verstovsek, Srdan
    Borthakur, Gautam
    Ravandi, Farhad
    Cortes, Jorge
    BLOOD, 2007, 110 (11) : 272A - 273A
  • [48] Successful treatment of patients with acute myeloid leukemia and Myelodysplastic Syndrome by decitabine
    Bulbul, Hale
    Davulcu, Eren A.
    Atilla, Fatos D.
    Ulusoy, Yusuf
    Soyer, Nur
    Saydam, Guray
    KUWAIT MEDICAL JOURNAL, 2022, 54 (03): : 385 - 391
  • [49] Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia
    Attar, Eyal C.
    De Angelo, Daniel J.
    Supko, Jeffrey G.
    D'Amato, Ferdinando
    Zahrieh, David
    Sirulnik, Andres
    Wadleigh, Martha
    Ballen, Karen K.
    McAfee, Steve
    Miller, Kenneth B.
    Levine, James
    Galinsky, Ilene
    Trehu, Elizabeth G.
    Schenkein, David
    Neuberg, Donna
    Stone, Richard M.
    Amrein, Philip C.
    CLINICAL CANCER RESEARCH, 2008, 14 (05) : 1446 - 1454
  • [50] Down syndrome patients with relapsed acute myelogenous leukemia.
    Loew, TW
    Gamis, A
    Smith, FO
    Massey, GV
    Woods, WG
    Hilden, JM
    Lange, B
    Alonzo, TA
    Chang, M
    Gerbing, RB
    BLOOD, 2004, 104 (11) : 215B - 215B
12345